Dopamine

DBL Dopamine, Dopamine (Juno)

Strength

40 mg/mL (volume: 5 mL)

IV administration

Dilute to 3.2 mg/mL or weaker and give as a continuous infusion, preferably via a central line.

Maximum concentration if necessary: 6 mg/mL, preferably via a central line.

Administration via umbilical artery catheter is not recommended.

Refer to local guidelines.

Other routes of administration

IM: Not recommended.

SC: Not recommended.

Compatible IV fluids

Glucose 5%

Glucose 10%

Sodium chloride 0.9%

Glucose 5% and sodium chloride 0.9%

Glucose 5% and sodium chloride 0.45%

Y-site only:

Hartmann’s

Potassium chloride 20 mmol/L

Ringer's 

Y-site only and dopamine 3.2 mg/mL or weaker:

Plasma-Lyte 148

Additional information

Extravasation risk. 

Seek specialist advice as soon as possible.

Continuous cardiac monitoring required during administration.

Use only when facilities for cardiac monitoring and cardio-respiratory resuscitation exist.

Taper the infusion slowly when discontinuing treatment; abrupt discontinuation may cause hypotension.

Solution should be clear and colourless or slightly yellow. Do not use if solution is discoloured.

Protect from light during storage.